Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.

Back

Oliver Hampton, PhD

How whole exome sequencing is helping oncology researchers reach new heights

Oliver Hampton is the VP of Bioinformatics and Biostatistics at M2GEN. He leads and supports the Avatar program as well as other collaborative projects between M2GEN, Pharma, and ORIEN. Prior to joining M2GEN, he led the Platform Informatics team at the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center. 

Click on the featured content below to learn how M2GEN is accelerating the discovery, development, and delivery of new findings in oncology research studies.

Collaborator content

M2GEN’s ORIEN Avatar program accelerates oncology research with a custom xGen Exome Research Panel

In this webinar series, Oliver walks us through how his team at M2GEN have leveraged IDT’s xGen™ Exome Hyb Panel to advance their oncology research program.

Learn more

Whole Exome Sequencing Handbook

In this three-part series handbook, we provide an overview of one of Geneseeq’s published studies and the new discoveries that were made from using our xGen™ Exome Hyb Panel.

Learn more